BMO Capital Initiates Coverage On Dorman Products with Outperform Rating, Announces Price Target of $180
Author: Benzinga Newsdesk | September 18, 2025 06:06am
BMO Capital analyst Tristan Thomas-Martin initiates coverage on Dorman Products (NASDAQ:DORM) with a Outperform rating and announces Price Target of $180.